August 27, 2024
Now available NEMLUVIO®
NEMLUVIO® (nemolizumab-ilto) for injection, for subcutaneous use, is an interleukin-31 receptor antagonist indicated for the treatment of adults with prurigo nodularis.
August 27, 2024
NEMLUVIO® (nemolizumab-ilto) for injection, for subcutaneous use, is an interleukin-31 receptor antagonist indicated for the treatment of adults with prurigo nodularis.